Reuters logo
BRIEF-Ronin Trading, SW Investment Management nominate James Egan to Peregrine Pharmaceuticals Board
October 10, 2017 / 5:16 PM / in 6 days

BRIEF-Ronin Trading, SW Investment Management nominate James Egan to Peregrine Pharmaceuticals Board

Oct 10 (Reuters) - Ronin Trading, LLC and SW Investment Management LLC:

* Ronin Trading and SW Investment Management announce additional nomination to Board of Peregrine Pharmaceuticals

* Ronin Trading and SW Investment Management - ‍nomination of James (Jamie) J. Egan, for election to Peregrine’s Board at co’s 2017 annual meeting

* ‍Ronin Trading and SW Investment Management say collectively have beneficial ownership of about 8.9% of Peregrine’s outstanding shares of common stock​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below